title: Is the ``$1000 Genome'' really $1000? Understanding the full benefits and costs of genomic sequencing.
authors: Center for Translational and Policy Research on Personalized Medicine, Department of Clinical Pharmacy, University of California at San Francisco, UCSF, San Francisco, CA, USA.
authors: Kathryn A
authors: KA
authors: Phillips
authors: Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA.
authors: Mark J
authors: MJ
authors: Pletcher
authors: Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA.
authors: Uri
authors: U
authors: Ladabaum
mesh_terms: D003198:Computer Simulation; D003362:Cost-Benefit Analysis; D020022:Genetic Predisposition to Disease / Q000235:genetics; D005820:Genetic Testing / Q000191:economics*; D023281:Genomics / Q000191:economics*; D006801:Humans; D008403:Mass Screening / Q000191:economics; D017059:Models, Econometric; D009369:Neoplasms / Q000235:genetics
keywords: Sequencing; cost-effectiveness; economics; price